NYSE:GCOGenesco Stock Price, Forecast & News

Genesco's stock was trading at $24.11 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GCO stock has decreased by 20.4% and is now trading at $19.19.
View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesco in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Genesco.

Genesco is scheduled to release its next quarterly earnings announcement on Friday, September 4th 2020.
View our earnings forecast for Genesco.

Genesco Inc. (NYSE:GCO) released its earnings results on Tuesday, June, 9th. The company reported ($3.65) earnings per share for the quarter, missing the Zacks' consensus estimate of ($2.52) by $1.13. The business earned $279.20 million during the quarter, compared to analysts' expectations of $306.47 million. Genesco had a positive return on equity of 2.57% and a negative net margin of 4.03%. The business's revenue was down 43.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.36 EPS.
View Genesco's earnings history.

Genesco announced that its board has approved a stock buyback program on Friday, May 3rd 2019, which authorizes the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 11.7% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's management believes its stock is undervalued.

4 Wall Street analysts have issued 12-month price objectives for Genesco's stock. Their forecasts range from $26.00 to $53.00. On average, they expect Genesco's share price to reach $35.75 in the next twelve months. This suggests a possible upside of 86.3% from the stock's current price.
View analysts' price targets for Genesco.

Media coverage about GCO stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Genesco earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term.
View the latest news about Genesco.

Genesco saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 2,120,000 shares, an increase of 11.0% from the July 15th total of 1,910,000 shares. Based on an average daily volume of 386,400 shares, the days-to-cover ratio is currently 5.5 days. Currently, 15.4% of the company's shares are sold short.
View Genesco's Short Interest.

Some companies that are related to Genesco include TJX Companies (TJX), Ross Stores (ROST), GAP (GPS), Foot Locker (FL), Urban Outfitters (URBN), American Eagle Outfitters (AEO), Guess? (GES), Buckle (BKE), Abercrombie & Fitch (ANF), Zumiez (ZUMZ), Designer Brands (DBI), Childrens Place (PLCE), Shoe Carnival (SCVL), Caleres (CAL) and Citi Trends (CTRN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesco investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Intelsat (I), Micron Technology (MU), Transocean (RIG), Bank of America (BAC), Ciena (CIEN) and American Eagle Outfitters (AEO).

Genesco trades on the New York Stock Exchange (NYSE) under the ticker symbol "GCO."

Genesco's stock is owned by many different retail and institutional investors. Top institutional investors include LSV Asset Management (3.54%), Smith Graham & Co. Investment Advisors LP (1.27%), Foundry Partners LLC (1.18%), Principal Financial Group Inc. (0.71%), Robeco Institutional Asset Management B.V. (0.64%) and SG Americas Securities LLC (0.55%). Company insiders that own Genesco stock include Daniel E Ewoldsen, Kathleen Mason, Mario Gallione, Marty G Dickens, Robert J Dennis and Thurgood Marshall Jr.
View institutional ownership trends for Genesco.

GCO stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., LSV Asset Management, Alberta Investment Management Corp, Principal Financial Group Inc., Nisa Investment Advisors LLC, New York State Teachers Retirement System, Pacer Advisors Inc., and Texas Permanent School Fund. Company insiders that have sold Genesco company stock in the last year include Daniel E Ewoldsen, and Kathleen Mason.
View insider buying and selling activity for Genesco.

GCO stock was bought by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Virtu Financial LLC, Foundry Partners LLC, UBS Group AG, Exchange Traded Concepts LLC, Wedge Capital Management L L P NC, Smith Graham & Co. Investment Advisors LP, and Pinnacle Financial Partners Inc..
View insider buying and selling activity for Genesco.

Shares of GCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GCO stock can currently be purchased for approximately $19.19.

Genesco has a market capitalization of $281.75 million and generates $2.20 billion in revenue each year. The company earns $61.38 million in net income (profit) each year or $4.58 on an earnings per share basis. Genesco employs 22,050 workers across the globe.

The official website for Genesco is www.genesco.com.

Genesco's mailing address is Genesco Park 1415 Murfreesboro Pike, NASHVILLE TN, 37217. The company can be reached via phone at 615-367-7000 or via email at [email protected]